News

BioPharma Dive2d

FDA’s new accelerated pathway may open pharma up to risks, as well as benefits

Faster review times could leave drugmakers vulnerable to litigation, while new Trump administration priorities add more ...
Hosted on MSN2mon

FDA wants to use AI to speed up drug approval process - MSN

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in even more automation amid thousands of federal ...
Yahoo3m

FDA approves updated Pfizer COVID shots but limits access for some kids and adults

Pfizer said in a release its vaccine is now approved for all seniors to protect against the virus this fall. But the Food and Drug Administration narrowed its ... The new restrictions — previewed by ...
Los Angeles Business Journal9d

Atara Makes Second Try With FDA

Thousand Oaks-based immunotherapy company Atara Biotherapeutics Inc., which is attempting to develop drugs from a T-cell ...
BioPharma Dive1d

Why an FDA decision on Stealth’s Barth drug could ripple through the rare disease field

Stealth secured a new agency review of its experimental therapy elamipretide after a rejection this year. The result could ...

This Day in History: FDA fully approves first COVID-19 vaccine on August 23, 2021

On August 23, 2021 the Food and Drug Administration fully approved the Phizer-BioNTech COVID-19 Vaccine for adults.
Cure Today1mon

Therapies Which Received FDA Approval in June: What You Should Know

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.